Share your views on the Unitary Patent and UPC

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Share your views on the Unitary Patent and UPC

What do you think about the Unitary Patent and Unified Patent Court? Law firm Wragge Lawrence Graham & Co is seeking the views of companies and professional advisers.

The firm’s survey only takes about 10 minutes to complete, and specific responses will not be attributed to individuals or organisations.

Anyone can complete the survey. The first page asks you to identify yourself as either a patent attorney or lawyer in private practice, an in-house lawyer/attorney or “other”.

Further questions concern European patent strategy and enforcement, views on the Unitary Patent and UPC and views on preparation for the new system, including opting-out

Managing IP’s recent survey (which was directed at in-house counsel only) found surprising support for the proposed system but a need for more information on costs.

Since then, there have been important developments, including regarding the renewal an court fees. We will update that survey in the light of recent developments and run it again before the summer.

A survey of in-house counsel commissioned by Allen & Overy, published in June last year, found that 49% would opt-in at least some of their patents to the UPC.

All our coverage of the Unitary Patent and UPC can be found at our dedicated page managingip.com/upc

more from across site and SHARED ros bottom lb

More from across our site

Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
Gift this article